naphtho(2,3-b)furan-4,9-dione has been researched along with Psoriasis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bannwitz, S; Müller, K; Prinz, H; Reichstein, A; Tentrop, J; Vortherms, S | 1 |
1 other study(ies) available for naphtho(2,3-b)furan-4,9-dione and Psoriasis
Article | Year |
---|---|
Synthesis and structure-activity relationships of lapacho analogues. 1. Suppression of human keratinocyte hyperproliferation by 2-substituted naphtho[2,3-b]furan-4,9-diones, activation by enzymatic one- and two-electron reduction, and intracellular genera
Topics: Cell Line; Cell Membrane; Cell Proliferation; Dermatologic Agents; Dicumarol; Furans; Humans; Keratinocytes; L-Lactate Dehydrogenase; NAD(P)H Dehydrogenase (Quinone); NADPH-Ferrihemoprotein Reductase; Naphthoquinones; Oxadiazoles; Psoriasis; Structure-Activity Relationship; Superoxides | 2012 |